Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
kinase enzyme; interacts specifically with cardiac troponin I; human homolog is a cardiac specific kinase. Additionally we are shipping TNNI3 Interacting Kinase Proteins (5) and TNNI3 Interacting Kinase Kits (3) and many more products for this protein.
Showing 10 out of 51 products:
Cow (Bovine) Polyclonal TNNI3K Primary Antibody for WB - ABIN2783205
Feng, Liu, Wang, Liu, Cao, Wang, Shi, Meng: AOP-1 interacts with cardiac-specific protein kinase TNNI3K and down-regulates its kinase activity. in Biochemistry. Biokhimii͡a 2008
using novel genetic animal models and newly developed small-molecule TNNI3K inhibitors, we demonstrated that TNNI3K-mediated IR injury occurs through impaired mitochondrial function and is in part dependent on p38 MAPK (show MAPK14 Antibodies).
we demonstrate that mutation of TNNI3K, encoding a heart-specific kinase known to modulate murine cardiac conduction and myocardial function, underlies a familial syndrome of electrical and myopathic heart disease in humans.
TNNI3K mediates cell signaling to modulate cardiac response to stress.
Results suggest that TNNI3K overexpression induces cardiomyocytes hypertrophy and accelerates hypertrophy in hypertrophic cardiomyocytes.
The finding of a de novo mutation in TNNI3 (show TNNI3 Antibodies) (R204H) enabled a genetic diagnosis and counselling. We suggest that the previously reported overlap of functional and morphologic phenotypes in sarcomeric genes may also be a feature of TNNI3 (show TNNI3 Antibodies) mutations.
[review] TNNI3K is a novel cardiac troponin I-interacting kinase gene that may be involved in the development of cardiac hypertrophy.
cloning of TNNI3K which interacts specifically with cardiac troponin I (show TNNI3 Antibodies); data suggest that TNNI3K is a cardiac-specific kinase and plays important roles in the cardiac system
TNNI3K exhibits dual-specific kinase activity and forms dimers or oligomers that may be necessary for its activation
coexpression of AOP-1 (show PRDX3 Antibodies) inhibited TNNI3K kinase activity
TNNI3K promotes cardiomyogenesis, enhances cardiac performance, and protects the myocardium from ischemic injury by suppressing p38 (show CRK Antibodies)/JNK (show MAPK8 Antibodies)-mediated apoptosis.
Our data provide the first evidence for a role of Tnni3k in controlling the electrocardiographic PR interval indicating a function of Tnni3k in atrio-ventricular conduction
Data identified Tnni3k, Fpgt (show FPGT Antibodies) and H28 (show IFI44L Antibodies) as likely likely candidates for Vms1.
Tnni3k plays a critical role in the modulation of different forms of heart disease, and this protein may provide a novel target for therapeutic intervention.
This gene encodes a protein that belongs to the MAP kinase kinase kinase (MAPKKK) family of protein kinases. The protein contains ankyrin repeat, protein kinase and serine-rich domains and is thought to play a role in cardiac physiology.
serine/threonine-protein kinase TNNI3K
, TNNI3 interacting kinase
, cardiac ankyrin repeat kinase
, cardiac troponin I-interacting kinase
, TNNI3-interacting kinase